Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	The contents of the displayed table are downloaded as a file named "table.csv".
	A text longer than 100 characters is fully displayed or collapsed.

DR info

Clinical trials : 4 / Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 44

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countires)

ACZ885
   Novartis Pharma Services AG
      2010   Phase 2   EUCTR2010-020061-24-GB   Ireland;Italy;United Kingdom;
      2010   -   EUCTR2010-020061-24-IE   Ireland;Italy;United Kingdom;
ACZ885D
   NOVARTIS FARMA
      2010   -   EUCTR2010-020061-24-IT   Ireland;Italy;United Kingdom;
Canakinumab
   NOVARTIS FARMA
      2010   -   EUCTR2010-020061-24-IT   Ireland;Italy;United Kingdom;
Ilaris
   Novartis pharma AG
      -   Phase 3   EUCTR2017-001678-40-Outside-EU/EEA   Japan;
Recombinant human monoclonal antibody to human IL-1Beta of the IgG1/K class
   Novartis Pharma Services AG
      2010   Phase 2   EUCTR2010-020061-24-GB   Ireland;Italy;United Kingdom;
      2010   -   EUCTR2010-020061-24-IE   Ireland;Italy;United Kingdom;